Nova Ltd. (NASDAQ:NVMI – Get Free Report) Director Eitan Oppenhaim sold 1,290 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $581.20, for a total value of $749,748.00. Following the transaction, the director owned 6,421 shares of the company’s stock, valued at $3,731,885.20. This represents a 16.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Eitan Oppenhaim also recently made the following trade(s):
- On Tuesday, May 26th, Eitan Oppenhaim sold 1,504 shares of Nova stock. The shares were sold at an average price of $519.48, for a total transaction of $781,297.92.
Nova Price Performance
Shares of Nova stock traded down $16.11 during trading hours on Wednesday, reaching $511.77. The company’s stock had a trading volume of 164,984 shares, compared to its average volume of 405,173. The firm has a 50 day moving average price of $522.12 and a 200-day moving average price of $453.68. Nova Ltd. has a one year low of $232.73 and a one year high of $615.99. The stock has a market cap of $16.27 billion, a P/E ratio of 63.92, a P/E/G ratio of 4.23 and a beta of 1.75.
Wall Street Analyst Weigh In
Several brokerages have commented on NVMI. Citigroup upped their price objective on Nova from $520.00 to $595.00 and gave the company a “buy” rating in a research report on Friday, May 15th. Wall Street Zen raised shares of Nova from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Morgan Stanley set a $494.00 price target on Nova in a report on Thursday, May 14th. Weiss Ratings raised Nova from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 14th. Finally, Barclays raised their price objective on Nova from $465.00 to $600.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $545.50.
Read Our Latest Stock Analysis on Nova
Institutional Trading of Nova
A number of hedge funds have recently added to or reduced their stakes in NVMI. Smartleaf Asset Management LLC purchased a new position in Nova during the 4th quarter valued at about $29,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Nova in the 3rd quarter worth approximately $40,000. CIBC Private Wealth Group LLC boosted its stake in shares of Nova by 75.7% during the third quarter. CIBC Private Wealth Group LLC now owns 130 shares of the semiconductor company’s stock valued at $42,000 after purchasing an additional 56 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in shares of Nova by 2,042.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 150 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 143 shares in the last quarter. Finally, TD Private Client Wealth LLC purchased a new position in Nova during the fourth quarter valued at approximately $74,000. 82.99% of the stock is owned by hedge funds and other institutional investors.
About Nova
Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.
Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.
Featured Stories
- Five stocks we like better than Nova
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
